|
COL4A3BP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.065600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.755000E-01 |
| Normal-vs-Stage2 |
6.404800E-01 |
| Normal-vs-Stage3 |
7.398100E-03 |
| Normal-vs-Stage4 |
4.938400E-03 |
| Stage1-vs-Stage2 |
9.605800E-01 |
| Stage1-vs-Stage3 |
5.045500E-04 |
| Stage1-vs-Stage4 |
7.972700E-04 |
| Stage2-vs-Stage3 |
5.731800E-02 |
| Stage2-vs-Stage4 |
4.177600E-02 |
| Stage3-vs-Stage4 |
7.939200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.882800E-01 |
| Normal-vs-AfricanAmerican |
3.423600E-01 |
| Normal-vs-Asian |
8.759000E-01 |
| Caucasian-vs-AfricanAmerican |
4.897000E-01 |
| Caucasian-vs-Asian |
9.829000E-01 |
| AfricanAmerican-vs-Asian |
8.255600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.303400E-01 |
| Normal-vs-Female |
5.448200E-01 |
| Male-vs-Female |
9.363400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.961400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.180400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.948400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.076840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.559800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.639600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.231000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.996200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.996000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.454200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.204160E-01 |
| Normal-vs-Grade 2 |
1.536220E-01 |
| Normal-vs-Grade 3 |
8.107500E-02 |
| Normal-vs-Grade 4 |
1.82394999999058E-05 |
| Grade 1-vs-Grade 2 |
1.654980E-01 |
| Grade 1-vs-Grade 3 |
1.010040E-02 |
| Grade 1-vs-Grade 4 |
1.361940E-04 |
| Grade 2-vs-Grade 3 |
3.060500E-03 |
| Grade 2-vs-Grade 4 |
1.28249999953312E-07 |
| Grade 3-vs-Grade 4 |
4.920900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.401600E-02 |
| Normal-vs-ccB subtype |
7.948000E-02 |
| ccA subtype-vs-ccB subtype |
3.165300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.241600E-01 |
| Normal-vs-N1 |
3.717200E-01 |
| N0-vs-N1 |
4.601400E-01 |
|
|
